Loading...
Indian Pharmaceutical Exporter · #13 for Salmeterol · $245.0K export value · DGFT Verified
Pollomi Pharmaceutical Private Limited is the #13 Indian exporter of Salmeterol with $245.0K in export value and 6 verified shipments. Pollomi Pharmaceutical Private Limited holds a 0.3% market share in Salmeterol exports across 1 countries.
| UNITED ARAB EMIRATES | $3.9M | 396 | 8.0% |
| SOUTH AFRICA | $3.7M | 74 | 7.6% |
| SRI LANKA | $2.9M | 86 | 6.0% |
| AUSTRALIA | $2.6M | 52 | 5.4% |
| PHILIPPINES | $1.9M | 77 | 3.8% |
| GERMANY | $1.8M | 36 | 3.7% |
India exports Salmeterol to 90 countries. The top destination is CHILE (20.0%), followed by MOROCCO and BELGIUM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CIPLA MAROC | MOROCCO | $4.4M | 88 |
| PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR | TURKEY | $3.3M | 66 |
| BREATHEFREE LANKA PVT LTD | SRI LANKA | $2.1M | 64 |
| LABORATORIOS RECALCINE SA.. | CHILE | $2.0M | 64 |
| H.ESSERS & ZONEN INTERNATIONAL TRAN | BELGIUM | $1.8M | 137 |
| CIPLA AUSTRALIA PTY LTD, | AUSTRALIA | $950.0K | 19 |
| PHARMAX PHARMACEUTICALS FZ LLC | UNITED ARAB EMIRATES | $550.0K | 11 |
| SANDOZ PTY LTD. SANDOZ | AUSTRALIA | $500.0K | 10 |
| SANDOZ PTY LTD | AUSTRALIA | $450.0K | 9 |
| ALLOGA UK LTD | UNITED KINGDOM | $150.0K | 3 |
India's Salmeterol is purchased by 370 buyers worldwide. The top buyer is CIPLA MAROC (MOROCCO), followed by PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR and BREATHEFREE LANKA PVT LTD.
India exported $68.9M worth of Salmeterol through 7,006 shipments from 148 suppliers to 90 countries, serving 370 buyers globally. Pollomi Pharmaceutical Private Limited contributes $245.0K to this total, accounting for 0.3% of India's Salmeterol exports.
Pollomi Pharmaceutical Private Limited's average Salmeterol shipment value is $40.8K per consignment, based on 6 shipments totaling $245.0K.
Pollomi Pharmaceutical Private Limited ranks #13 among 148 Indian Salmeterol exporters with a 0.3% market share. The top 3 exporters are CIPLA LIMITED ($55.7M), HETERO LABS LIMITED ($6.4M), MEDISPRAY LABORATORIES PRIVATE LIMITED ($1.1M). Pollomi Pharmaceutical Private Limited processed 6 shipments to 1 destination countries.
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | KOPRAN LIMITED | $392.3K | 9 | 1 | $43.6K |
| 12 | CADILA HEALTHCARE LIMITED | $307.6K | 16 | 2 | $19.2K |
| 13 | POLLOMI PHARMACEUTICAL PRIVATE LIMITED ★ | $245.0K | 6 | 1 | $40.8K |
| 14 | PRIME PHARMACEUTICALS PRIVATE LIMITED | $215.3K | 21 | 2 | $10.3K |
| 15 | MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED | $184.2K | 5 | 2 | $36.8K |
Pollomi Pharmaceutical Private Limited ranks #13 among 148 Indian Salmeterol exporters. Average shipment value of $40.8K compared to the market average of $465.4K. The closest competitors by value are KOPRAN LIMITED and CADILA HEALTHCARE LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,431 | 20.4% |
| SAHAR AIR | 1,278 | 18.2% |
| DELHI AIR | 1,169 | 16.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 633 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 405 | 5.8% |
| Delhi Air | 309 | 4.4% |
| Bombay Air | 228 | 3.3% |
| JNPT/ NHAVA SHEVA SEA | 191 | 2.7% |
Latest developments and market context
Detailed market intelligence for Salmeterol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 90+ countries, 370+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Pollomi Pharmaceutical Private Limited's Salmeterol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Pollomi Pharmaceutical Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Pollomi Pharmaceutical Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salmeterol. For current shipment-level data, contact TransData Nexus.